Global Intravenous Solutions Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 143496
  • calendar_today Published On: Jan, 2019
  • file_copy Pages: 117
  • list Medical Devices

Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.

Scope of the Report:

The North America average price of intravenous solutions is in the increasing trend, from 404 USD/K Units in 2011 to 417 USD/K Units in 2016.

The classification of intravenous solutions includes crystalloids, colloids, and other. The proportion of crystalloids in 2016 is about 78%, and the proportion keeps steady.

Intravenous solutions are widely used for basic IV solutions, nutrient infusion solution. The most proportion of intravenous solutions is basic IV solutions, and the consumption in 2016 is 2627 M units.

USA is the largest consumption place, with a consumption market share nearly 81% in 2016. Following USA, Canada is the second largest consumption place with the consumption market share of 10%. Mexico consumption market share is about 7%.

The market is relatively concentrated. Baxter, Hospira, B. Braun Melsungen, Fresenius Kabi.are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

The worldwide market for Intravenous Solutions is expected to grow at a CAGR of roughly 2.0% over the next five years, will reach 1930 million US$ in 2024, from 1710 million US$ in 2019, according to a new study.

This report focuses on the Intravenous Solutions in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Baxter

Hospira

B. Braun Melsungen

Fresenius Kabi

Claris Lifesciences

Grifols

Vifor Pharma

JW Life Science

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Crystalloids

Colloids

Others

Market Segment by Applications, can be divided into

Basic IV Solutions

Nutrient Infusion Solution

Others

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Intravenous Solutions product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Intravenous Solutions, with price, sales, revenue and global market share of Intravenous Solutions in 2017 and 2018.

Chapter 3, the Intravenous Solutions competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Intravenous Solutions breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Intravenous Solutions market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Intravenous Solutions sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Intravenous Solutions Introduction

1.2 Market Analysis by Type

1.2.1 Crystalloids

1.2.2 Colloids

1.2.3 Others

1.3 Market Analysis by Applications

1.3.1 Basic IV Solutions

1.3.2 Nutrient Infusion Solution

1.3.3 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2014-2024)

1.4.1.2 Canada Market States and Outlook (2014-2024)

1.4.1.3 Mexico Market States and Outlook (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2014-2024)

1.4.2.2 France Market States and Outlook (2014-2024)

1.4.2.3 UK Market States and Outlook (2014-2024)

1.4.2.4 Russia Market States and Outlook (2014-2024)

1.4.2.5 Italy Market States and Outlook (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2014-2024)

1.4.3.2 Japan Market States and Outlook (2014-2024)

1.4.3.3 Korea Market States and Outlook (2014-2024)

1.4.3.4 India Market States and Outlook (2014-2024)

1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2014-2024)

1.4.4.2 Egypt Market States and Outlook (2014-2024)

1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)

1.4.4.4 South Africa Market States and Outlook (2014-2024)

1.4.4.5 Turkey Market States and Outlook (2014-2024)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Baxter

2.1.1 Business Overview

2.1.2 Intravenous Solutions Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Baxter Intravenous Solutions Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.2 Hospira

2.2.1 Business Overview

2.2.2 Intravenous Solutions Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Hospira Intravenous Solutions Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.3 B. Braun Melsungen

2.3.1 Business Overview

2.3.2 Intravenous Solutions Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 B. Braun Melsungen Intravenous Solutions Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.4 Fresenius Kabi

2.4.1 Business Overview

2.4.2 Intravenous Solutions Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Fresenius Kabi Intravenous Solutions Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.5 Claris Lifesciences

2.5.1 Business Overview

2.5.2 Intravenous Solutions Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Claris Lifesciences Intravenous Solutions Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.6 Grifols

2.6.1 Business Overview

2.6.2 Intravenous Solutions Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Grifols Intravenous Solutions Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.7 Vifor Pharma

2.7.1 Business Overview

2.7.2 Intravenous Solutions Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Vifor Pharma Intravenous Solutions Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.8 JW Life Science

2.8.1 Business Overview

2.8.2 Intravenous Solutions Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 JW Life Science Intravenous Solutions Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Intravenous Solutions Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global Intravenous Solutions Sales and Market Share by Manufacturer (2017-2018)

3.2 Global Intravenous Solutions Revenue and Market Share by Manufacturer (2017-2018)

3.3 Market Concentration Rate

3.3.1 Top 3 Intravenous Solutions Manufacturer Market Share in 2018

3.3.2 Top 6 Intravenous Solutions Manufacturer Market Share in 2018

3.4 Market Competition Trend

4 Global Intravenous Solutions Market Analysis by Regions

4.1 Global Intravenous Solutions Sales, Revenue and Market Share by Regions

4.1.1 Global Intravenous Solutions Sales and Market Share by Regions (2014-2019)

4.1.2 Global Intravenous Solutions Revenue and Market Share by Regions (2014-2019)

4.2 North America Intravenous Solutions Sales and Growth Rate (2014-2019)

4.3 Europe Intravenous Solutions Sales and Growth Rate (2014-2019)

4.4 Asia-Pacific Intravenous Solutions Sales and Growth Rate (2014-2019)

4.5 South America Intravenous Solutions Sales and Growth Rate (2014-2019)

4.6 Middle East and Africa Intravenous Solutions Sales and Growth Rate (2014-2019)

5 North America Intravenous Solutions by Country

5.1 North America Intravenous Solutions Sales, Revenue and Market Share by Country

5.1.1 North America Intravenous Solutions Sales and Market Share by Country (2014-2019)

5.1.2 North America Intravenous Solutions Revenue and Market Share by Country (2014-2019)

5.2 United States Intravenous Solutions Sales and Growth Rate (2014-2019)

5.3 Canada Intravenous Solutions Sales and Growth Rate (2014-2019)

5.4 Mexico Intravenous Solutions Sales and Growth Rate (2014-2019)

6 Europe Intravenous Solutions by Country

6.1 Europe Intravenous Solutions Sales, Revenue and Market Share by Country

6.1.1 Europe Intravenous Solutions Sales and Market Share by Country (2014-2019)

6.1.2 Europe Intravenous Solutions Revenue and Market Share by Country (2014-2019)

6.2 Germany Intravenous Solutions Sales and Growth Rate (2014-2019)

6.3 UK Intravenous Solutions Sales and Growth Rate (2014-2019)

6.4 France Intravenous Solutions Sales and Growth Rate (2014-2019)

6.5 Russia Intravenous Solutions Sales and Growth Rate (2014-2019)

6.6 Italy Intravenous Solutions Sales and Growth Rate (2014-2019)

7 Asia-Pacific Intravenous Solutions by Country

7.1 Asia-Pacific Intravenous Solutions Sales, Revenue and Market Share by Country

7.1.1 Asia-Pacific Intravenous Solutions Sales and Market Share by Country (2014-2019)

7.1.2 Asia-Pacific Intravenous Solutions Revenue and Market Share by Country (2014-2019)

7.2 China Intravenous Solutions Sales and Growth Rate (2014-2019)

7.3 Japan Intravenous Solutions Sales and Growth Rate (2014-2019)

7.4 Korea Intravenous Solutions Sales and Growth Rate (2014-2019)

7.5 India Intravenous Solutions Sales and Growth Rate (2014-2019)

7.6 Southeast Asia Intravenous Solutions Sales and Growth Rate (2014-2019)

8 South America Intravenous Solutions by Country

8.1 South America Intravenous Solutions Sales, Revenue and Market Share by Country

8.1.1 South America Intravenous Solutions Sales and Market Share by Country (2014-2019)

8.1.2 South America Intravenous Solutions Revenue and Market Share by Country (2014-2019)

8.2 Brazil Intravenous Solutions Sales and Growth Rate (2014-2019)

8.3 Argentina Intravenous Solutions Sales and Growth Rate (2014-2019)

8.4 Colombia Intravenous Solutions Sales and Growth Rate (2014-2019)

9 Middle East and Africa Intravenous Solutions by Countries

9.1 Middle East and Africa Intravenous Solutions Sales, Revenue and Market Share by Country

9.1.1 Middle East and Africa Intravenous Solutions Sales and Market Share by Country (2014-2019)

9.1.2 Middle East and Africa Intravenous Solutions Revenue and Market Share by Country (2014-2019)

9.2 Saudi Arabia Intravenous Solutions Sales and Growth Rate (2014-2019)

9.3 Turkey Intravenous Solutions Sales and Growth Rate (2014-2019)

9.4 Egypt Intravenous Solutions Sales and Growth Rate (2014-2019)

9.5 Nigeria Intravenous Solutions Sales and Growth Rate (2014-2019)

9.6 South Africa Intravenous Solutions Sales and Growth Rate (2014-2019)

10 Global Intravenous Solutions Market Segment by Type

10.1 Global Intravenous Solutions Sales, Revenue and Market Share by Type (2014-2019)

10.1.1 Global Intravenous Solutions Sales and Market Share by Type (2014-2019)

10.1.2 Global Intravenous Solutions Revenue and Market Share by Type (2014-2019)

10.2 Crystalloids Sales Growth and Price

10.2.1 Global Crystalloids Sales Growth (2014-2019)

10.2.2 Global Crystalloids Price (2014-2019)

10.3 Colloids Sales Growth and Price

10.3.1 Global Colloids Sales Growth (2014-2019)

10.3.2 Global Colloids Price (2014-2019)

10.4 Others Sales Growth and Price

10.4.1 Global Others Sales Growth (2014-2019)

10.4.2 Global Others Price (2014-2019)

11 Global Intravenous Solutions Market Segment by Application

11.1 Global Intravenous Solutions Sales Market Share by Application (2014-2019)

11.2 Basic IV Solutions Sales Growth (2014-2019)

11.3 Nutrient Infusion Solution Sales Growth (2014-2019)

11.4 Others Sales Growth (2014-2019)

12 Intravenous Solutions Market Forecast (2019-2024)

12.1 Global Intravenous Solutions Sales, Revenue and Growth Rate (2019-2024)

12.2 Intravenous Solutions Market Forecast by Regions (2019-2024)

12.2.1 North America Intravenous Solutions Market Forecast (2019-2024)

12.2.2 Europe Intravenous Solutions Market Forecast (2019-2024)

12.2.3 Asia-Pacific Intravenous Solutions Market Forecast (2019-2024)

12.2.4 South America Intravenous Solutions Market Forecast (2019-2024)

12.2.5 Middle East and Africa Intravenous Solutions Market Forecast (2019-2024)

12.3 Intravenous Solutions Market Forecast by Type (2019-2024)

12.3.1 Global Intravenous Solutions Sales Forecast by Type (2019-2024)

12.3.2 Global Intravenous Solutions Market Share Forecast by Type (2019-2024)

12.4 Intravenous Solutions Market Forecast by Application (2019-2024)

12.4.1 Global Intravenous Solutions Sales Forecast by Application (2019-2024)

12.4.2 Global Intravenous Solutions Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Intravenous Solutions Picture

Table Product Specifications of Intravenous Solutions

Figure Global Sales Market Share of Intravenous Solutions by Types in 2018

Please fill the form below, to recieve the report sample


+1